ABAXIS Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 16 Posts
Zoetis To Acquire Abaxis For $83 Per Share, Or Approximately $2B In Aggregate
Article By: The Fly Wednesday, May 16, 2018 10:16 AM EDT
Zoetis Inc. and Abaxis, Inc. announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis for $83 per share in cash, or approximately $2B in aggregate.
In this article: ABAX, ZTS
Read
J.P.Morgan Healthcare Conference #1: Investors Move Into Life Science Stocks-Bouncing Off The Bottom
Article By: Rod Raynovich Tuesday, January 12, 2016 8:28 PM EDT
We have a long way to recover in this bear market. The IBB​ touched near 52 week lows yesterday at $287 and is currently at $296 after a failed bounce then a recovery. We are down about 12% over five days.
In this article: ALR, JPM, NGS, TMO, RHHBY, CPHD, IBB, ILMN, ABAX, AFFX, QGEN
Read
Rayno Molecular Diagnostics And Tools Update: CPHD, HOLX, PACB
Article By: Rod Raynovich Wednesday, December 2, 2015 6:31 PM EDT
Lackluster revenue growth has tempered stock gains since Q3 earnings reports however the sector has always had good investment potential due to M&A and new products. Stocks are up from October lows.
In this article: CPHD, ILMN, ABAX, HOLX, PACB, QGEN
Read
Rayno Tools And Molecular Diagnostics: Looking For Value
Article By: Rod Raynovich Thursday, November 5, 2015 7:30 PM EDT
Life Science stocks took a big hit over the past summer and many have not fully recovered. The important metric to watch is sales growth because many of the smaller cap companies are still lagging in earnings growth so the PE tells you very little.
In this article: ALR, CPHD, GHDX, ILMN, LMNX, QDEL, ABAX, HOLX, NEOG, PACB, QGEN, FMI
Read
Slower Growth In Diagnostics Stocks Except For NexGen Sequencing And Molecular
Article By: Rod Raynovich Thursday, June 11, 2015 8:30 PM EDT
New technologies in diagnostics and tools are driving growth: NexGen sequencing, molecular and “point-of-care” testing platforms and veterinary testing. The sector is a laggard due to slowing sales and earnings growth.
In this article: ABAX, ALR, HOLX, ILMN, SQNM, TMO, EXAS, FMI, VRML, IWO Also: AXDX, GNMK, NVTA, HTGM
Read
Rayno Portfolio Picks Up On Q1 Results: AMGN, ILMN
Article By: Rod Raynovich Wednesday, April 22, 2015 5:45 AM EDT
Amgen stock was up 1.5 % yesterday, and over 2% after hours to $172. Total Q1 revenues were up 11% to $5B compared to prior quarter in 2014 and EPS increased by 33% to $2.48
In this article: AMGN, ILMN, ALXN, BIIB, GILD, REGN, RHHBY, ABAX, HOLX, QGEN, TMO, INCY, VRTX
Read
Snap-Back Rally In Biotech-But Lagging Other Sectors
Article By: Rod Raynovich Monday, March 30, 2015 11:15 PM EDT
We are in Day Two of the biotech rally that was sparked last Friday with the rumor supported by a Deutsche Bank analyst that Biomarin (BMRN) was a takeover target.
In this article: BMRN, ABBV, PCYC, XBI, XLV, REGN, AMGN, ALKS, CLVS, CLDX, FCSC, FMI, GLYC, ABAX, PACB, XON
Read
Rayno Life Sciences DX And Tools Update: 2015 Q1 Winners ALR,FMI,HOLX
Article By: Rod Raynovich Friday, March 13, 2015 6:37 AM EDT
Here are the 2015 YTD top five winners among our focus stocks...
In this article: ABAX, ALR, CSII, FMI, HOLX
Read
Rayno Dx And Tools: 2015 Q1 Mid Quarter Update-FMI, CSII, HOLX, ALR
Article By: Rod Raynovich Thursday, February 19, 2015 4:41 PM EDT
Major ETFs (FBT,IBB,XBI) are up about 10% YTD and our top performers are up over 10%.
In this article: FMI, CSII, HOLX, ALR, FBT, IBB, XBI, CPHD, ILMN, ABAX, QGEN, TMO, EXAS, GHDX, NEOG, NSTG, PACB, QDEL, SQNM, VRML
Read
Medtronic Tops Q3 Earnings, Revenues; Offers Joint Q4 View
Article By: Zacks Investment Research Tuesday, February 17, 2015 2:26 PM EDT
Medtronic plc reported third-quarter fiscal 2015 financial results of the legacy Medtronic Inc., following the completion of the long-awaited $42.9 billion takeover of its Irish counterpart, Covidien, on Jan 26.
In this article: MDT, VASC, ABAX, PAHC
Read
Boston Scientific Tops Q4 Earnings, Revenues Miss Mark
Article By: Zacks Investment Research Wednesday, February 4, 2015 12:11 PM EDT
Boston Scientific Corporation (BSX) reported adjusted earnings per share (EPS) (after considering certain one-time adjustments other than amortization expense) of 15 cents in the fourth quarter of 2014, 15.4% ahead of the year-ago adjusted number.
In this article: BSX, ABAX, CSII, ICUI
Read
Rayno Dx And Tools 2014 Performance YTD: ABAX, EXAS, ILMN, PACB, SQNM
Article By: Rod Raynovich Monday, December 29, 2014 2:52 PM EDT
Many big winners are among Rayno Diagnostics and Tools stocks in 2014.
In this article: ABAX, EXAS, ILMN, PACB, SQNM
Read
Zacks Equity Research Neogen Q2 Earnings & Revenues Lag Estimates, Rise Y/Y
Article By: Zacks Investment Research Thursday, December 18, 2014 11:59 AM EDT
Neogen Corp. (NEOG) posted adjusted earnings of 21 cents per share in the second quarter of fiscal 2015 (ended Nov 30, 2014) which missed the Zacks Consensus Estimate by a penny.
In this article: ABAX, OSUR, ICUI, NEOG
Read
Abaxis - Chart Of The Day
Article By: Jim Van Meerten Monday, September 15, 2014 5:45 PM EDT
The Chart of the Day belongs to Abaxis. I found the stock by sorting the All Time High list for the highest technical buy signals then used the Flipchart feature to review the charts. Since the Trend Spotter signaled a buy on 7/25 the stock gained 14.23%.
In this article: ABAX
Read
5 Small Cap Wonders
Article By: Jim Van Meerten Monday, September 15, 2014 12:20 PM EDT
Small Caps have been having a rough time lately. In fact the S&P 600 Small Cap index is lower this morning than it was 6 months ago.
In this article: CALM, CVGW, ABAX, VDSI, PRLX
Read
Today's Best Small Caps: ABAX, AXE, MTRX, TNGO, STC
Article By: Jim Van Meerten Friday, January 17, 2014 5:00 PM EDT
Today's list includes Abaxis (ABAX), Anixter International (AXE), Matrix Service Co (MTRX), Tangoe (TNGO), and Stewart Information Services (STC).
In this article: AXE, STC, MTRX, ABAX, TNGO
Read
1 to 16 of 16 Posts